Center for Vaccine Research

Paul Duprex in a checkered shirt
A scientific detective story that unfolded in Pitt’s Center for Vaccine Research unearths how the virus that causes COVID-19 evolves new variants that evade antibodies. Director Paul Duprex says this evolution is why it’s important to develop multiple tools to fight the pandemic.
A depiction of the coronavirus in blue, red and white
With the delivery of the first batches of SARS-CoV-2 vaccines, providers and laypeople alike have questions about the technologies behind them. Pitt Med magazine enlisted Jeremy Berg, Pitt’s associate senior vice chancellor for science strategy and planning in the health sciences, to help explain.
Pittsburgh Lends Expertise, Arms to Moderna Vaccine Development
On Monday, Moderna became the second company to announce promising early results of its Phase 3 COVID-19 vaccine trial. The Pittsburgh site, led by Pitt’s Judy Martin, has seen more than 250 Pittsburghers roll up their sleeves to volunteer.
A depiction of the coronavirus
Four Pitt experts offer their thoughts on Pfizer’s announcement today of a vaccine that early data show is more than 90% effective in preventing COVID-19.
A person in a face mask and a white shirt holds a model in a gloved hand
Research published today in Science describes a new method to extract tiny but extremely powerful antibody fragments from llamas, which could then be fashioned into inhalable therapeutics for COVID-19. Tune in today at 3 p.m. EST for a press conference on the findings.
A Zoom call with eight visible participants
If you missed yesterday’s panel discussion on rolling out a vaccine for COVID-19, watch the recording here, or read highlights from a wide-ranging discussion.
A man in a light blue shirt leaning against a reflective surface
Pitt’s Jonas Salk Chair for Vaccine Research explains why we need multiple candidate vaccines, what’s special about SARS-CoV-2 and why he’s hopeful about the future.
A man in a white shirt
When Jonas Salk and his Pitt team, supported by March of Dimes, tackled the polio pandemic, they came up with creative ways to make and distribute the vaccine. Dr. Rahul Gupta of March of Dimes explains why that sort of approach is needed to eradicate COVID-19 today.
Angus in a blue suit
Published as part of a four-article package today in JAMA, research led by Pitt’s Derek Angus found that an inexpensive treatment of steroids can substantially improve survival in critically ill COVID-19 patients. The findings, part of a multi-site global trial, were so stark that the World Health Organization is updating its treatment guidance for the disease.
Roc wearing a blue Pitt t-shirt
Proceeds from a new Pitt Athletics T-shirt are supporting the Center for Vaccine Research in its work developing a COVID-19 vaccine to emerge “Over Fate and Foe Victorious.”